Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Fractures in pediatric Ewing sarcoma.

Wagner LM, Neel MD, Pappo AS, Merchant TE, Poquette CA, Rao BN, Rodriguez-Galindo C.

J Pediatr Hematol Oncol. 2001 Dec;23(9):568-71. Review.

PMID:
11902298
2.

Primary Ewing tumor of the vertebrae: clinical characteristics, prognostic factors, and outcome.

Venkateswaran L, Rodriguez-Galindo C, Merchant TE, Poquette CA, Rao BN, Pappo AS.

Med Pediatr Oncol. 2001 Jul;37(1):30-5.

PMID:
11466720
3.

Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.

Rodriguez-Galindo C, Poquette CA, Daw NC, Tan M, Meyer WH, Cleveland JL.

Med Pediatr Oncol. 2001 Jun;36(6):605-11.

PMID:
11344491
4.

Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice.

Thompson J, Guichard SM, Cheshire PJ, Richmond LB, Poquette CA, Ragsdale ST, Webber B, Lorsbach R, Danks MK, Houghton PJ.

Cancer Chemother Pharmacol. 2001 Mar;47(3):211-21.

PMID:
11320664
5.

Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.

Athale UH, Shurtleff SA, Jenkins JJ, Poquette CA, Tan M, Downing JR, Pappo AS.

J Pediatr Hematol Oncol. 2001 Feb;23(2):99-104.

PMID:
11216714
6.

Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.

Spunt SL, McCarville MB, Kun LE, Poquette CA, Cain AM, Brandao L, Pappo AS.

J Pediatr Hematol Oncol. 2001 Feb;23(2):93-8. Erratum in: J Pediatr Hematol Oncol 2001 Dec;23(9):637.

PMID:
11216713
7.

Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial.

Meyer WH, Pratt CB, Poquette CA, Rao BN, Parham DM, Marina NM, Pappo AS, Mahmoud HH, Jenkins JJ, Harper J, Neel M, Fletcher BD.

J Clin Oncol. 2001 Jan 1;19(1):171-82.

PMID:
11134210
8.

Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.

Houghton PJ, Stewart CF, Cheshire PJ, Richmond LB, Kirstein MN, Poquette CA, Tan M, Friedman HS, Brent TP.

Clin Cancer Res. 2000 Oct;6(10):4110-8.

9.

Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors.

Rodriguez-Galindo C, Poquette CA, Marina NM, Head DR, Cain A, Meyer WH, Santana VM, Pappo AS.

J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):321-9.

PMID:
10959902
10.

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.

Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ, Houghton PJ, Harris LC.

Med Pediatr Oncol. 2000 Aug;35(2):96-103.

PMID:
10918230
11.

Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?

Hayes-Jordan AA, Spunt SL, Poquette CA, Cain AM, Rao BN, Pappo AS, Shochat SJ.

J Pediatr Surg. 2000 Jun;35(6):948-53; discussion 953-4.

PMID:
10873042
12.

Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience.

Daw NC, Mahmoud HH, Meyer WH, Jenkins JJ, Kaste SC, Poquette CA, Kun LE, Pratt CB, Rao BN.

Cancer. 2000 May 1;88(9):2172-80.

PMID:
10813731
13.

Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.

Marina NM, Poquette CA, Cain AM, Jones D, Pratt CB, Meyer WH.

J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):112-8.

PMID:
10779023
14.

Hemangiopericytoma in children and infants.

Rodriguez-Galindo C, Ramsey K, Jenkins JJ, Poquette CA, Kaste SC, Merchant TE, Rao BN, Pratt CB, Pappo AS.

Cancer. 2000 Jan 1;88(1):198-204.

PMID:
10618624
15.

Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.

Thompson J, George EO, Poquette CA, Cheshire PJ, Richmond LB, de Graaf SS, Ma M, Stewart CF, Houghton PJ.

Clin Cancer Res. 1999 Nov;5(11):3617-31.

16.

Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.

Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, Jenkins JJ, Santana VM, Pratt CB, Pappo AS.

J Clin Oncol. 1999 Dec;17(12):3697-705.

PMID:
10577841
17.

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.

Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC, Bowman LC, Ma MK, Hoffer FA, Meyer WH, Pappo AS, Walter AW, Houghton PJ.

J Clin Oncol. 1999 Jun;17(6):1815-24.

PMID:
10561220
18.

Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.

Parasuraman S, Langston J, Rao BN, Poquette CA, Jenkins JJ, Merchant T, Cain A, Pratt CB, Pappo AS.

J Pediatr Hematol Oncol. 1999 Sep-Oct;21(5):370-7.

PMID:
10524449
19.

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.

Marina NM, Pappo AS, Parham DM, Cain AM, Rao BN, Poquette CA, Pratt CB, Greenwald C, Meyer WH.

J Clin Oncol. 1999 Jan;17(1):180-90.

PMID:
10458232
20.

Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children's Research Hospital experience.

Pappo AS, Rao BN, Jenkins JJ, Merchant T, Poquette CA, Cain A, Pratt CB.

Med Pediatr Oncol. 1999 Aug;33(2):76-82.

PMID:
10398180
21.

Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.

Shah AB, Hudson MM, Poquette CA, Luo X, Wilimas JA, Kun LE.

Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):867-77.

PMID:
10386644
22.

Increased mortality after successful treatment for Hodgkin's disease.

Hudson MM, Poquette CA, Lee J, Greenwald CA, Shah A, Luo X, Thompson EI, Wilimas JA, Kun LE, Crist WM.

J Clin Oncol. 1998 Nov;16(11):3592-600.

PMID:
9817280
23.

Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.

McPake CR, Tillman DM, Poquette CA, George EO, Houghton JA, Harris LC.

Oncol Res. 1998;10(5):235-44.

PMID:
9802058

Supplemental Content

Loading ...
Support Center